Russell Investments Group’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-187
| Closed | -$351 | – | 3806 |
|
|
2024
Q3 | $351 | Hold |
187
| – | – | ﹤0.01% | 3601 |
|
|
2024
Q2 | $368 | Hold |
187
| – | – | ﹤0.01% | 3520 |
|
|
2024
Q1 | $574 | Hold |
187
| – | – | ﹤0.01% | 3191 |
|
|
2023
Q4 | $435 | Hold |
187
| – | – | ﹤0.01% | 3134 |
|
|
2023
Q3 | $748 | Hold |
187
| – | – | ﹤0.01% | 3365 |
|
|
2023
Q2 | $759 | Hold |
187
| – | – | ﹤0.01% | 3339 |
|
|
2023
Q1 | $575 | Sell |
187
-1
| -0.5% | -$3 | ﹤0.01% | 3095 |
|
|
2022
Q4 | $506 | Hold |
188
| – | – | ﹤0.01% | 2882 |
|
|
2022
Q3 | $0 | Hold |
188
| – | – | ﹤0.01% | 2984 |
|
|
2022
Q2 | $1K | Hold |
188
| – | – | ﹤0.01% | 2871 |
|
|
2022
Q1 | $2K | Hold |
188
| – | – | ﹤0.01% | 2730 |
|
|
2021
Q4 | $3K | Hold |
188
| – | – | ﹤0.01% | 2986 |
|
|
2021
Q3 | $4K | Hold |
188
| – | – | ﹤0.01% | 3019 |
|
|
2021
Q2 | $11K | Hold |
188
| – | – | ﹤0.01% | 3187 |
|
|
2021
Q1 | $23K | Sell |
188
-1,620
| -90% | -$198K | ﹤0.01% | 3063 |
|
|
2020
Q4 | $205K | Buy |
1,808
+1,493
| +474% | +$169K | ﹤0.01% | 2750 |
|
|
2020
Q3 | $36K | Buy |
315
+134
| +74% | +$15.3K | ﹤0.01% | 3105 |
|
|
2020
Q2 | $22K | Sell |
181
-21
| -10% | -$2.55K | ﹤0.01% | 3050 |
|
|
2020
Q1 | $38K | Sell |
202
-200
| -50% | -$37.6K | ﹤0.01% | 2900 |
|
|
2019
Q4 | $133K | Sell |
402
-72
| -15% | -$23.8K | ﹤0.01% | 2823 |
|
|
2019
Q3 | $153K | Sell |
474
-190
| -29% | -$61.3K | ﹤0.01% | 2704 |
|
|
2019
Q2 | $286K | Buy |
664
+80
| +14% | +$34.5K | ﹤0.01% | 2429 |
|
|
2019
Q1 | $330K | Buy |
584
+39
| +7% | +$22K | ﹤0.01% | 2477 |
|
|
2018
Q4 | $162K | Buy |
+545
| New | +$162K | ﹤0.01% | 2637 |
|